Literature DB >> 4213507

Toxicity of camptothecin (NSC-100880).

U Schaeppi, R W Fleischman, D A Cooney.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4213507

Source DB:  PubMed          Journal:  Cancer Chemother Rep 3        ISSN： 0069-0139


× No keyword cloud information.
  16 in total

Review 1.  New cytotoxic drugs and targets in oncology.

Authors:  J H Beijnen
Journal:  Pharm Weekbl Sci       Date:  1992-08-21

2.  Alcohol-, diol-, and carbohydrate-substituted indenoisoquinolines as topoisomerase I inhibitors: investigating the relationships involving stereochemistry, hydrogen bonding, and biological activity.

Authors:  Katherine E Peterson; Maris A Cinelli; Andrew E Morrell; Akhil Mehta; Thomas S Dexheimer; Keli Agama; Smitha Antony; Yves Pommier; Mark Cushman
Journal:  J Med Chem       Date:  2011-06-28       Impact factor: 7.446

3.  Integrative population pharmacokinetic and pharmacodynamic dose finding approach of the new camptothecin compound namitecan (ST1968).

Authors:  M Joerger; D Hess; A Delmonte; E Gallerani; A Fasolo; L Gianni; S Cresta; P Barbieri; S Pace; C Sessa
Journal:  Br J Clin Pharmacol       Date:  2015-06-03       Impact factor: 4.335

4.  Baicalin induces human mucoepidermoid carcinoma Mc3 cells apoptosis in vitro and in vivo.

Authors:  Xiao-Fang Xu; Bo-Lei Cai; Su-Min Guan; Yan Li; Jun-Zheng Wu; Yong Wang; Bin Liu
Journal:  Invest New Drugs       Date:  2010-03-06       Impact factor: 3.850

5.  Actively targeted low-dose camptothecin as a safe, long-acting, disease-modifying nanomedicine for rheumatoid arthritis.

Authors:  Otilia May Yue Koo; Israel Rubinstein; Hayat Onyüksel
Journal:  Pharm Res       Date:  2010-12-04       Impact factor: 4.200

6.  Vaccination with photodynamic therapy-treated macrophages induces highly suppressive T-regulatory cells.

Authors:  Oleg E Akilov; Mei X Wu; Yongzhu Jin; Zhuoyan Zhou; Larisa J Geskin; Louis D Falo; Tayyaba Hasan
Journal:  Photodermatol Photoimmunol Photomed       Date:  2011-04       Impact factor: 3.135

7.  Identification, synthesis, and biological evaluation of metabolites of the experimental cancer treatment drugs indotecan (LMP400) and indimitecan (LMP776) and investigation of isomerically hydroxylated indenoisoquinoline analogues as topoisomerase I poisons.

Authors:  Maris A Cinelli; P V Narasimha Reddy; Peng-Cheng Lv; Jian-Hua Liang; Lian Chen; Keli Agama; Yves Pommier; Richard B van Breemen; Mark Cushman
Journal:  J Med Chem       Date:  2012-12-07       Impact factor: 7.446

8.  Inhibition of retrovirus-induced disease in mice by camptothecin.

Authors:  E Priel; E Aflalo; G Chechelnitsky; D Benharroch; M Aboud; S Segal
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

9.  Structure-Based Drug Design and Identification of H2O-Soluble and Low Toxic Hexacyclic Camptothecin Derivatives with Improved Efficacy in Cancer and Lethal Inflammation Models in Vivo.

Authors:  Peichen Pan; Jiean Chen; Xijian Li; Miyang Li; Huidong Yu; Jean J Zhao; Jing Ni; Xuwen Wang; Huiyong Sun; Sheng Tian; Feng Zhu; Feng Liu; Yong Huang; Tingjun Hou
Journal:  J Med Chem       Date:  2018-09-27       Impact factor: 7.446

Review 10.  Cancer therapies utilizing the camptothecins: a review of the in vivo literature.

Authors:  Vincent J Venditto; Eric E Simanek
Journal:  Mol Pharm       Date:  2010-04-05       Impact factor: 4.939
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.